Currency market
  • Nurcapital Corporation (NCL.H) has amended the terms of the non-brokered private placement announced on September 27, 2022
  • The private placement consists of 33,333 common shares in the capital of the company issued at a price of $0.15 per common share
  • The pricing for the offering may be adjusted by the TSX Venture Exchange (TSXV)
  • Nurcapital Corporation Ltd. a capital-pool company
  • Nurcapital Corporation Ltd. opened trading at $0.20 per share

Nurcapital Corporation (NCL.H) has amended the terms of the non-brokered private placement announced on September 27, 2022.

The private placement consists of 33,333 common shares in the capital of the company issued at a price of $0.15 per common share.

The pricing for the offering may be adjusted by the TSX Venture Exchange (TSXV). The potential re-pricing may be required as the company is not currently trading.

The company expects to be reinstated for trading shortly and will issue a follow-up news release if the pricing for the private placement is amended.

The pricing would be no less than the Discounted Market Price (as defined in TSXV Policy 1.1) once the company is reinstated. The common shares issued in line with the private placement will be held in trust and will be subject to escrow as required by the TSXV.

In addition to applicable escrow provisions, the common shares are subject to a statutory hold period of four months plus one day from the date of issuance, expiring January 28, 2023, in accordance with applicable securities legislation.

The offering constitutes a “related party transaction” under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (MI 61-101).

Nurcapital Corporation Ltd. was incorporated under the Business Corporations Act (Ontario) on January 8, 2015, and listed as a capital pool company on the NEX Board of the TSXV.

Nurcapital Corporation Ltd. opened trading at $0.20 per share.


More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

Sun Life misses core profit estimates for first time in 12 quarters

Sun Life (TSX:SLF) faces a setback as it reports its Q1 2024 results, missing core profit estimates for the first time in 12 quarters.

Canopy Growth fuels turnaround story with fresh capital

Canopy Growth (TSX:WEED) continues its turnaround story with a C$96.3 million exchange and subscription deal with an institutional investor.